Two novel MRI biomarkers of brain tissue microstructure may be useful in determining disease burden in pediatric patients with multiple sclerosis (MS) and other demyelinating diseases, according to data presented at RSNA 2022.
Two novel MRI biomarkers of brain tissue microstructure may be useful in determining disease burden in pediatric patients with multiple sclerosis (MS) and other demyelinating diseases, according to data presented at RSNA 2022.